Literature DB >> 16142704

Transgene-activated mesenchymal cells for articular cartilage repair: a comparison of primary bone marrow-, perichondrium/periosteum- and fat-derived cells.

Jung Park1, Kolja Gelse, Susi Frank, Klaus von der Mark, Thomas Aigner, Holm Schneider.   

Abstract

BACKGROUND: Adult primary mesenchymal cells of different origin which can be obtained with minor donor site morbidity are considered for articular cartilage repair. This study aims at a comparison of their chondrogenic potential.
METHODS: Mesenchymal cells were isolated from perichondrium/periosteum, bone marrow or fat of adult rats and found to be positive for the stem-cell-related antigens Sca-1, c-Kit, CD10, CD13 and CD90 by reverse transcription polymerase chain reaction (RT-PCR). Chondrogenic differentiation was induced by applying recombinant bone morphogenetic protein-2 (BMP-2) or adenoviral vectors carrying BMP-2 cDNA, followed by micromass culture. The stimulated cells were characterized by RT-PCR, cell proliferation and apoptosis assays. Expression of aggrecan, collagen type I, II, IX and X and alkaline phosphatase genes was analyzed by RT-PCR, immunofluorescence and immunohistochemistry in comparison with unstimulated control cells. Adenovirally stimulated cells were transplanted into mechanically generated partial-thickness cartilage lesions in the patellar groove of the rat femur. Quality and integration of the repair tissues were assessed by histochemical and immunohistochemical methods.
RESULTS: Stimulation with BMP-2 or AdBMP-2 led to an up-regulation of cartilage-specific gene expression in all three cell populations studied, most rapidly and prominently in the perichondrial/periosteal cells, which showed a 3200-fold increase of type II collagen mRNA and reached the highest absolute levels of type II and IX collagen transcripts after stimulation. Similar results were obtained for the bone marrow stromal cells (BMSC), while the respective transcript levels in fat stromal cells declined after an initial more than 30-fold elevation. Following transplantation in vivo, AdBMP-2-infected perichondrial/periosteal cells produced a proteoglycan-rich, type II collagen-positive matrix with only faint staining for type I collagen. The repair tissue originating from AdBMP-2-infected BMSC showed less intense type II collagen staining, but a relatively proteoglycan-rich matrix, weakly positive for type I collagen. Transgene-activated fat stromal cells formed rather fibrous tissue mainly composed of type I collagen. Unstimulated cells of the three different populations gave only rise to fibrous tissue.
CONCLUSIONS: Perichondrium/periosteum-derived cells and BMSC seem superior to cells isolated from fat with respect to forming hyaline cartilaginous tissue. A chondrogenic stimulus, e.g. by transfer of BMP-2 cDNA, appears to be required for initiation and support of chondrogenic differentiation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16142704     DOI: 10.1002/jgm.826

Source DB:  PubMed          Journal:  J Gene Med        ISSN: 1099-498X            Impact factor:   4.565


  38 in total

1.  Analysis of OPLA scaffolds for bone engineering constructs using human jaw periosteal cells.

Authors:  Dorothea Alexander; Jürgen Hoffmann; Adelheid Munz; Björn Friedrich; Jürgen Geis-Gerstorfer; Siegmar Reinert
Journal:  J Mater Sci Mater Med       Date:  2007-12-25       Impact factor: 3.896

2.  The periosteum as a cellular source for functional tissue engineering.

Authors:  Emily J Arnsdorf; Luis M Jones; Dennis R Carter; Christopher R Jacobs
Journal:  Tissue Eng Part A       Date:  2009-09       Impact factor: 3.845

Review 3.  Concise review: the periosteum: tapping into a reservoir of clinically useful progenitor cells.

Authors:  Hana Chang; Melissa L Knothe Tate
Journal:  Stem Cells Transl Med       Date:  2012-05-30       Impact factor: 6.940

Review 4.  Mesenchymal stem cells at the intersection of cell and gene therapy.

Authors:  Timothy J Myers; Froilan Granero-Molto; Lara Longobardi; Tieshi Li; Yun Yan; Anna Spagnoli
Journal:  Expert Opin Biol Ther       Date:  2010-12       Impact factor: 4.388

Review 5.  Gene therapy for chondral and osteochondral regeneration: is the future now?

Authors:  Daniele Bellavia; F Veronesi; V Carina; V Costa; L Raimondi; A De Luca; R Alessandro; M Fini; G Giavaresi
Journal:  Cell Mol Life Sci       Date:  2017-09-01       Impact factor: 9.261

6.  Enhanced in vitro chondrogenesis of primary mesenchymal stem cells by combined gene transfer.

Authors:  Andre F Steinert; Glyn D Palmer; Carmencita Pilapil; Ulrich Nöth; Christopher H Evans; Steven C Ghivizzani
Journal:  Tissue Eng Part A       Date:  2009-05       Impact factor: 3.845

7.  Comparative chondrogenesis of human cell sources in 3D scaffolds.

Authors:  R Seda Tigli; Sourabh Ghosh; Michael M Laha; Nirupama K Shevde; Laurence Daheron; Jeffrey Gimble; Menemşe Gümüşderelioglu; David L Kaplan
Journal:  J Tissue Eng Regen Med       Date:  2009-07       Impact factor: 3.963

8.  Osteogenic and adipogenic cell fractions isolated from postnatal mouse calvaria.

Authors:  Pieter Steenhuis; K M Carr; G J Pettway; M A Ignelzi
Journal:  Cells Tissues Organs       Date:  2008-12-17       Impact factor: 2.481

Review 9.  Chondrogenic differentiation of mesenchymal stem cells: challenges and unfulfilled expectations.

Authors:  Rodrigo A Somoza; Jean F Welter; Diego Correa; Arnold I Caplan
Journal:  Tissue Eng Part B Rev       Date:  2014-05-27       Impact factor: 6.389

10.  Hypertrophy is induced during the in vitro chondrogenic differentiation of human mesenchymal stem cells by bone morphogenetic protein-2 and bone morphogenetic protein-4 gene transfer.

Authors:  Andre F Steinert; Benedikt Proffen; Manuela Kunz; Christian Hendrich; Steven C Ghivizzani; Ulrich Nöth; Axel Rethwilm; Jochen Eulert; Christopher H Evans
Journal:  Arthritis Res Ther       Date:  2009-10-02       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.